Congress Organised by the Eurasian
Association of Therapists

«The Eurasian Congress
of Internal Medicine»

Under the auspices of the Ministry of Health of the Russian Federation
October 26-28, 2022
Online
About the congress
We are glad to welcome healthcare professionals to the Eurasian Congress of Internal Medicine.

You are welcome to attend online sessions held in English involving international experts.
Online
The broadcast will take place on the same website
Broadcast
Key topics:
  • Scientific breakthrough in cardiology amid the COVID-19 pandemic: groundbreaking research findings in 2020-2021 and 2022.
  • Endocrinology Today: Focus on Type 2 Diabetes and Thyroid Pathology. Diagnostics and Current Evidence-Based Treatment Strategies.
  • CHF: New Treatment Trends and Approaches. Patient Prognosis Evaluation: how to Improve Quality of Life?
  • The problem of COPD within the internal medicine clinic. Expectations and changes.
  • Treatment Challenges in Comorbidities: Specifics of Post-COVID Management of Patients.
  • Issues in prescribing antibiotic therapy in view of increasing antimicrobial resistance. Current perspective on the problem.
  • Nephrology for General Practitioners: focus on Acute Kidney Injury and Chronic Kidney Disease.
  • Cardiovascular risk management in real clinical practiceю.
Programme
The full version of the program is provided in the Russian version of the website: https://xconf.euat.ru
Please find below the sessions held in English.
09:40-12:00
Plenary session
  • Biotechnological platforms in diagnostics and treatment. Classics and innovations
    Kudlay D.
  • Novel nicotine delivery systems – a pulmonologist's view
    Aisanov Z.
  • Management of CHF patients: the Republic of Kazakhstan’ experience
    Bekbosynova M.
  • Chronic viral hepatitis B – are treatment options available?
    Nikitin I.
  • New risk factor management paradigms
    Arutyunov G.
  • HFpEF – long-awaited moment of change in therapy
    Fomin I.
11:30-12:50
Special Session «Do we know everything about CHF? Resolved and unresolved issues»
  • Do we have any progress in the diagnosis of CHF?
    Ageev F.
  • Current image of a patient with CHF
    Vinogradova N.
  • Acute decompensation of CHF in patients with impaired carbohydrate metabolism
    Koziolova N.
  • Infections with CHF with low PV: what do we know today?
    Arutyunov A.
  • Treatment of CHF from low to preserved PV – do we have a breakthrough in improving the prognosis of life?
    Lopatin Yu.
  • On the issue of organization of medical care for patients with CHF
    Fomin I.
12:50-13:30
Panel discussion of relevant topics
11:30-12:20
Speed Session «Lost chronicles: Problems in diagnosis and treatment of patients with chronic diseases»
  • New risk groups to look for CHF and CKD
    Arutyunov A.
  • Diagnosing patients with CHF – a hidden threat or a decisive battle
    Mareev Yu.
  • New era in CKD treatment – a long-awaited reality in terms of new discoveries
    Bobkova I.
  • Dapagliflozin in the treatment of patients with CHF – light at the end of the tunnel
    Petar Seferovic
  • Augmented reality: a full spectrum discovery in the treatment of patients with CHF
    Vladimir Miloradovic
  • Unraveled chronicles: accumulated data on the safety of iSGLT-2 use
    Petunina N.
  • Risks of AKI in hospitalized patients with CHF
    Fomin I.
12:20-13:00
Panel discussion of relevant topics
13:00-14:30
Break
14:30-16:00
Symposium «Clinical aspects of managing patients with carbohydrate metabolism disorders»

Chairman:
Galstyan G.

  • Lower extremity lesion in diabetes mellitus
    Galstyan G.
  • Beta-blockers for diabetes: avoiding or saving lives?
    Starostina E.
  • Diabetes mellitus and pregnancy: what a therapist needs to know
    Shestakova T.
  • Effects of SGLT2 inhibitors on renal function in patients with diabetes mellitus
    Ivana Bozic Antic
16:00-16:30
Break
16:30-18:00
Symposium «Targeting the heart of diabetes»

Chairman:
Goran Cvijovic

  • Diastolic heart failure: challenges of diagnosis and treatment
    Ana Djordjevic-Dikic
  • SGLT-2 inhibitors in HFpEF. What to expect?
    Vojislav Giga
  • Cardiovascular benefits of SGLT-2 inhibitors in diabetes patients: A true gift for your Sweetheart!
    Marko Stojanovic
  • Cardiovascular effects of glp-1 ra therapy in diabetic patients
    Goran Cvijovic
Speakers
The Congress will be attended by leading experts, scientists and physicians specialising in various areas of medicine from the Russian Federation, the Republic of Kazakhstan, the Republic of Belarus, the Republic of Armenia as well as from Serbia and Romania.
If you have any questions about
cooperation, please contact
us at the following address
About the Association

The Eurasian Association of Internal Medicine is an independent association that provides an opportunity for its members to share experience and discuss crucial problems of evidence-based medicine and clinical practice.

Among the Association’s main goals is to disseminate information about ground-breaking research in the field of internal medicine.

The Association holds free events for medical specialists letting them earn CME credit points.

Past Events
Watch recordings of past events of the Eurasian Association of Internal Medicine
«Innovations in internal medicine» 2022
Open
«Comorbid patients in the pandemic era» 2021
Open
«Therapeutic aspects of cardiology practice» 2021
Open
«Eurasian Association of Internal Medicine» 2021
Open